[ad_1]
Completion of the acquisition is subject to court approval and is contingent upon successful closing
CHELMSFORD, Mass.–(BUSINESS WIRE)–INCH®Asahi Kasei, a company that produces medical devices and related software solutions, announced today that it has been the winning bid in the auction to acquire the ventilator business of Vyaire Medical as part of Vyaire’s Chapter 11 bankruptcy proceedings. Completion of the acquisition is subject to court approval at a sales hearing and is contingent upon a successful closing, which is expected to occur in the coming weeks.
ZOLL is a global leader in critical care and related diagnostic software and tools, and its solutions are used around the world to diagnose and treat patients with serious cardiopulmonary and respiratory diseases. Since 2014, ZOLL has manufactured ventilation devices and accessories designed specifically for transporting critically ill patients.
“Respiratory care has been core to ZOLL’s business strategy for many years,” said Jon Rennert, ZOLL CEO. “If the acquisition is successfully completed, the addition of the Vyaire ventilator to ZOLL’s portfolio will enhance our ability to serve a broader range of clinicians and patients.”
Until new ownership is finalized, Vyaire fans and customers should continue to contact Vyaire (for more information, visit https://www.vyaire.com/contact-us).
Additional Background
On June 10, 2024, Vyaire Medical announced that it had voluntarily filed for Chapter 11 bankruptcy protection in the United States. The Chapter 11 filing allows Vyaire to continue operating while it seeks to sell its business units, including the Vyaire ventilator business. Since the bankruptcy filing, Vyaire’s day-to-day operations have continued with little interruption, and Vyaire continues to serve its ventilator customers and maintain the equipment needed to operate safely and efficiently.
About Zoll
ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance emergency care and save lives while improving clinical and operational efficiencies. With products for defibrillation and monitoring, circulation augmentation and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL offers a broad range of technologies to help physicians, emergency services, and patients. Firefighters, as well as lay rescuers, can improve outcomes for patients with critical cardiopulmonary conditions. For more information, visit www.zoll.com.
About Asahi Kasei
Asahi Kasei Group contributes to the lives of people around the world. Since its founding in 1922 as an ammonia and cellulose fiber business, Asahi Kasei has grown steadily by proactively transforming its business portfolio to meet the changing needs of each era. With more than 49,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world’s challenges through its three business areas: Materials, Home and Healthcare. Its Healthcare business includes equipment and systems for critical care, dialysis, therapeutic plasmapheresis and biotherapeutics manufacturing, as well as pharmaceuticals and diagnostics. For more information, visit www.asahi-kasei.com.
Asahi Kasei is also committed to sustainability initiatives and is working towards a carbon neutral society by 2050. For more information, visit https://www.asahi-kasei.com/sustainability.
The original source language text of this statement is the official authorized version. Translations are provided only as adaptations and must be checked against the original language text, which is the only legally binding version.
Contact Details
media:
Matt Hogan
ZOLL Medical Corporation
+1 (978) 805-6561
(email protected)
[ad_2]
Source link
